Term
|
Definition
H1 Receptor Antagonists, 1st Generation
+ sedation
In OTC “cold” drugs |
|
|
Term
|
Definition
H1 Receptor Antagonists, 1st Generation
+++ sedation
Widely used; not in newborns
Not with ototoxic antibiotics
Used in motion sickness
PD |
|
|
Term
|
Definition
H1 Receptor Antagonists, 1st Generation
motion sickness, vestibular disturbances |
|
|
Term
|
Definition
H1 Receptor Antagonists, 1st Generation
cardiotoxic at high levels, esp with antimicrobials (lethal ventricular arrhythmias) |
|
|
Term
|
Definition
H1 Receptor Antagonist, 2nd generation
No sedation!
Lower risk of cardiac effects (it’s the active metabolite that is not toxic from terfenadine) |
|
|
Term
|
Definition
H1 Receptor Antagonist, 2nd generation
No sedation
Longer action
No sign. Cardiac effects |
|
|
Term
|
Definition
H1 Receptor Antagonist, 2nd generation
oral, long-acting antihistamine that is similar chemically to loratadine |
|
|
Term
|
Definition
| H1 Receptor Antagonist, 2nd generation |
|
|
Term
|
Definition
Release Inhibitor
inhibit immunologically triggered degranulation (e.g., lung mast cells)
work only in prophylaxis!
nasal spray, eye drops |
|
|
Term
|
Definition
Release Inhibitor
inhibit immunologically triggered degranulation (e.g., lung mast cells)
work only in prophylaxis!
nasal spray, eye drops
inhibition of degranulation (e.g., by cromolyn sodium) prevents effects of all=much more efficient! |
|
|
